Ignite Creation Date:
2024-05-06 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06015269
Status:
RECRUITING
Last Update Posted:
2023-08-29
First Post:
2023-08-23
Brief Title:
Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery
Sponsor:
Shanghai Cell Therapy Group CoLtd
Organization:
Shanghai Cell Therapy Group CoLtd
Study Overview
Official Title:
Exploratory Study on Baize DC Injection in Preventing Recurrence and Metastasis After Radical Tumor Surgery
Status:
RECRUITING
Status Verified Date:
2023-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an exploratory study on the safety immune response and preliminary effectiveness of single arm fixed dose therapy
Detailed Description:
This study is a clinical study exploring the safety immune response and preliminary efficacy of a single arm 1x107cells dose
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None